FeesSafety
Pluang+

Metaplanet shifts ¥8B from bond repayment to Bitcoin purchases, increasing BTC allocation to ¥33.4B.

Market News
02 Nov 2026, 14:11 WIB
Tokenpost
View Source
Bullish
Metaplanet shifts ¥8B from bond repayment to Bitcoin purchases, increasing BTC allocation to ¥33.4B.

Metaplanet redirected ¥8 billion initially set for bond repayment to increase its Bitcoin purchases, raising the allocation from ¥25.422 billion to ¥33.422 billion. This change follows the early repayment of its Series 20 ordinary bond to EVO FUND, originally due in April 2027. The company maintains ¥3.714 billion funding for its Bitcoin income generation business, signaling a strategic focus on digital assets going forward.

Metaplanet's recent financial move to redirect ¥8 billion towards Bitcoin purchases provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang as of Nov 02, 2026 18:41 WIB: out of 50 priced assets, 5 rose and 44 fell today. Notable movers include BAT at Rp2.394 with a -5.78% change and 73% sell order activity, LINK at Rp204.007 down -4.52% with 80% sell orders, and LUNC at Rp0,75 down -4.46% with nearly balanced sell/buy orders.

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
26 minutes ago
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...

Company Fundamentals
Neutral
26 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
26 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
26 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
26 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App